摘要:
The rotating armature relay exhibits one or two ferromagnetic bars which are provided with an insulating covering in their central area. Contact springs are secured in the insulation covering, the contacting, free ends of said contact springs respectively interacting with cooperating contact elements anchored in a base body. As a result, a slide-free and, thus, low-friction actuation derives as, however, does relatively high friction at the contact locations, whereby contact impacts are suppressed and foreign layers are abraded from the contact surfaces.
摘要:
A device for conveying and dispensing liquid media such as casting resin has at least one piston pump having a cylinder chamber which forms a seal for a piston therein which is connected via an input opening to a feed container for receiving a supply of liquid therefrom. The cylinder chamber has an output opening and the piston is tubular in form having wall perforations in the region of the input opening for admitting the liquid to the interior of the piston and has a valve at a discharging end thereof for exit of the liquid from the piston. A seal is thus formed by which the piston operates entirely surrounded by the liquid medium to be dispensed and external seals between the piston and the atmosphere are eliminated.
摘要:
The present invention relates to a compound of formula I wherein R1, R2, R3, Ar, and n are as defined herein or to a pharmaceutically active acid addition salt. Compounds of formula I show a high affinity simultaneously to both the NK1 and the NK3 receptors (dual NK1/NK3 receptor antagonists), useful in the treatment of schizophrenia.
摘要:
The present invention provides a method for the treatment of schizophrenia which comprises administering a compound of formula wherein the substituents are as described herein or a pharmaceutically active acid-addition salt thereof. In particular, the invention provides methods for treating both positive and negative symptoms of schizophrenia through dual inhibition of NK1 and NK3 receptors. The invention also provides novel compounds with formula I and methods for preparing compounds of the invention.
摘要:
The present invention is concerned with a method of treating Alzheimer's disease by administering a therapeutically effective amount of a substituted imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine of formula I wherein R1, R2, and R3 are as defined herein, and their pharmaceutically acceptable acid addition salts. The invention also provides novel compounds of formula I-A and pharmaceutical compositions containing them.
摘要:
The present invention provides a method for the treatment of schizophrenia which comprises administering a compound of formula wherein the substituents are as described herein or a pharmaceutically active acid-addition salt thereof. In particular, the invention provides methods for treating both positive and negative symptoms of schizophrenia through dual inhibition of NK1 and NK3 receptors. The invention also provides novel compounds with formula I and methods for preparing compounds of the invention.
摘要:
A system for transporting small components, generally electrical components, arranged in a row comprising an arbitrary number of chain links. The components are accommodated within a cavity present in the chain links. The cavity is defined by at least two walls, at least one of which must be rigid, while the wall located opposite thereof is a resilient wall.
摘要:
The invention relates to compounds of the formula wherein R1 is lower alkyl, lower alkoxy, pyridinyl, pyrimidinyl, phenyl, —S-lower alkyl, —S(O)2-lower alkyl, —N(R)—(CH2)n—N(R)2, —O—(CH2)n—N(R)2, —N(R)2, or a cyclic tertiary amine of the group which may contain one additional heteroatom, selected from N, O or S, and wherein this group may be connected with the pyrimidine ring via the linker —O(CH2)n—; R2 is hydrogen, lower alkyl, lower alkoxy, halogen or trifluoromethyl; R3/R3′ is, independently from each other, hydrogen or lower alkyl; R4 is independently from each other halogen, trifluoromethyl or lower alkoxy; R5 is hydrogen or lower alkyl; R is, independently from each other, hydrogen or lower alkyl; X is —C(O)N(R)— or —N(R)C(O)—; Y is —O—, —S—, —SO2—, - or —N(R)—; n is 1,2,3 or 4; and m is 0,1 or 2; or a pharmaceutically acceptable acid addition salt thereof. The compound of the invention has affintity to the NK1 receptor and is therefore suitable in the treatment of diseases related to this recepor.
摘要翻译:本发明涉及式I的化合物,其中R 1为低级烷基,低级烷氧基,吡啶基,嘧啶基,苯基,-S-低级烷基,-S(O)2 - 低级烷基,-N(R) - (CH 2)n N (R)2,-O-(CH 2)n N(R)2,-N(R)2)或可以含有一个选自N,O或S的另外的杂原子的基团的环状叔胺, 可以通过连接基-O(CH 2)n - ; R 2是氢,低级烷基,低级烷氧基,卤素或三氟甲基与嘧啶环连接; R 3 / R 3'各自独立地为 R 4彼此独立地为卤素,三氟甲基或低级烷氧基; R 5为氢或低级烷基; R为彼此独立地为氢或低级烷基; X为-C (O)N(R) - 或-N(R)C(O) - ; Y是-O - , - S-,-SO 2 - , - 或-N(R) - ; n是1,2,3 或4; 和m为0,1或2;或其药学上可接受的酸加成盐。 本发明化合物对NK1受体具有亲和性,因此适用于治疗与该受体有关的疾病。
摘要:
The compounds of the related invention are related to 4-phenyl-pyridine derivatives connected by a bridge containing oxygen or nitrogen to a phenyl derivative.
摘要:
The invention relates to compounds of the formula wherein R is hydrogen, lower alkyl, lower alkoxy, halogen or trifluoromethyl; R1 is hydrogen or halogen; or R and R1 may be together —CH═CH—CH═CH—; R2 is hydrogen, halogen, trifluoromethyl, lower alkoxy or cyano; R3 is hydrogen, lower alkyl or form a cycloalkyl group; R4 is hydrogen, —N(R5)2, —N(R5)S(O)2-lower alkyl, —N(R5)C(O)R5 or a cyclic tertiary amine of the group R5 is, independently from each other, hydrogen, C3-6-cycloalkyl, benzyl or lower alkyl; R6 is hydrogen, hydroxy, lower alkyl, —N(R5)CO-lower alkyl, hydroxy-lower alkyl, cyano, —CHO or a 5- or 6 membered heterocyclic group, optionally bonded via an alkylene group, X is —C(O)N(R5)—, —(CH2)mO—, —(CH2)mN(R5)—, —N(R5)C(O)—, or —N(R5)(CH2)m—; n is 0-4; and m is 1 or 2; and to pharmaceutically acceptable acid addition salts thereof. It has been shown that the above mentioned compounds have a good affinity to the NK-1 receptor.